Analyst Price Target is $8.38
▲ +227.15% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Beauty Health in the last 3 months. The average price target is $8.38, with a high forecast of $23.00 and a low forecast of $2.00. The average price target represents a 227.15% upside from the last price of $2.56.
Current Consensus is
The current consensus among 14 contributing investment analysts is to hold stock in Beauty Health. This Hold consensus rating has held steady for over two years.
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.